Literature DB >> 22488521

Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells.

Ananda Mukherjee1, Parimal Karmakar.   

Abstract

To address the involvement of PTEN/Akt signaling in DNA repair and genomic stability, we developed a shRNA-mediated PTEN knockdown cell line from HEK293T cells and evaluated its response to etoposide by analyzing γH2AX and Rad51 foci formation, cell cycle analysis, and chromosome damage. HEK PTEN knockdown cells were impaired in DNA repair associated with loss of G2/M checkpoint and reduced Rad51 foci formation. Furthermore, inhibition of Akt did not restore etoposide-induced G2/M arrest in PTEN knockdown cells, suggesting that loss of G2/M checkpoint in PTEN knockdown cells is Akt-independent. On the other hand, these cells become sensitive to etoposide when Akt was inhibited. Thus, loss of G2/M checkpoint and reduction of Rad51-mediated homologous recombination is responsible for the genomic instability of PTEN knockdown cells where activated Akt additionally contribute to strong survival signal.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  API-59CJ-OMe; Akt; PTEN; Rad51; genomic instability; γH2AX

Mesh:

Substances:

Year:  2012        PMID: 22488521     DOI: 10.1002/mc.21903

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  13 in total

1.  High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation.

Authors:  Ann Christin Parplys; Jasna Irena Seelbach; Saskia Becker; Matthias Behr; Agnieszka Wrona; Camilla Jend; Wael Yassin Mansour; Simon Andreas Joosse; Horst-Werner Stuerzbecher; Helmut Pospiech; Cordula Petersen; Ekkehard Dikomey; Kerstin Borgmann
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  PTEN as a Guardian of the Genome: Pathways and Targets.

Authors:  Xinyi Fan; Jeffrey Kraynak; Jonathan P S Knisely; Silvia C Formenti; Wen H Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

Review 3.  Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?

Authors:  A Lester; R Rapkins; S Nixdorf; M Khasraw; K McDonald
Journal:  Clin Transl Oncol       Date:  2016-09-21       Impact factor: 3.405

Review 4.  PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation.

Authors:  Sheng-Qi Hou; Meng Ouyang; Andrew Brandmaier; Hongbo Hao; Wen H Shen
Journal:  Bioessays       Date:  2017-09-11       Impact factor: 4.345

5.  Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase.

Authors:  Todd R Mereniuk; Mohamed A M El Gendy; Ana M Mendes-Pereira; Christopher J Lord; Sunita Ghosh; Edan Foley; Alan Ashworth; Michael Weinfeld
Journal:  Mol Cancer Ther       Date:  2013-07-24       Impact factor: 6.261

6.  A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.

Authors:  Kevin J Arvai; Ya-Hsuan Hsu; Lobin A Lee; Dan Jones
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

7.  PTEN regulates DNA replication progression and stalled fork recovery.

Authors:  Jinxue He; Xi Kang; Yuxin Yin; K S Clifford Chao; Wen H Shen
Journal:  Nat Commun       Date:  2015-07-09       Impact factor: 14.919

8.  Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration.

Authors:  David P A Cohen; Loredana Martignetti; Sylvie Robine; Emmanuel Barillot; Andrei Zinovyev; Laurence Calzone
Journal:  PLoS Comput Biol       Date:  2015-11-03       Impact factor: 4.475

9.  Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner.

Authors:  Katharina Mueck; Simone Rebholz; Mozhgan Dehghan Harati; H Peter Rodemann; Mahmoud Toulany
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

10.  Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.

Authors:  Nouf Al-Subhi; Reem Ali; Tarek Abdel-Fatah; Paul M Moseley; Stephen Y T Chan; Andrew R Green; Ian O Ellis; Emad A Rakha; Srinivasan Madhusudan
Journal:  Breast Cancer Res Treat       Date:  2018-02-02       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.